A detailed history of Nordea Investment Management Ab transactions in Organon & Co. stock. As of the latest transaction made, Nordea Investment Management Ab holds 3,970,328 shares of OGN stock, worth $84.7 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,970,328
Previous 3,128,810 26.9%
Holding current value
$84.7 Million
Previous $45.1 Million 65.44%
% of portfolio
0.09%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$13.78 - $18.8 $11.6 Million - $15.8 Million
841,518 Added 26.9%
3,970,328 $74.6 Million
Q4 2023

Jan 10, 2024

BUY
$10.95 - $17.32 $32.6 Million - $51.6 Million
2,980,945 Added 2015.99%
3,128,810 $45.1 Million
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $1.01 Million - $1.44 Million
60,653 Added 69.55%
147,865 $2.57 Million
Q2 2023

Jul 07, 2023

SELL
$19.27 - $24.63 $70,239 - $89,776
-3,645 Reduced 4.01%
87,212 $1.81 Million
Q1 2023

Apr 19, 2023

SELL
$21.42 - $32.08 $147,862 - $221,448
-6,903 Reduced 7.06%
90,857 $2.14 Million
Q4 2022

Feb 08, 2023

BUY
$23.31 - $28.61 $68,414 - $83,970
2,935 Added 3.1%
97,760 $2.73 Million
Q3 2022

Oct 19, 2022

SELL
$23.4 - $34.25 $703,006 - $1.03 Million
-30,043 Reduced 24.06%
94,825 $2.28 Million
Q2 2022

Aug 09, 2022

BUY
$31.66 - $38.9 $3.95 Million - $4.86 Million
124,868 New
124,868 $4.31 Million
Q1 2022

Apr 11, 2022

SELL
$30.45 - $39.36 $25.1 Million - $32.4 Million
-824,377 Closed
0 $0
Q4 2021

Jan 20, 2022

BUY
$28.67 - $37.13 $4.73 Million - $6.13 Million
165,094 Added 25.04%
824,377 $25.2 Million
Q3 2021

Nov 01, 2021

SELL
$28.63 - $35.64 $17.8 Million - $22.2 Million
-623,184 Reduced 48.59%
659,283 $22 Million
Q3 2021

Nov 01, 2021

BUY
$28.63 - $35.64 $13.6 Million - $17 Million
476,651 Added 59.15%
1,282,467 $42.1 Million
Q2 2021

Jul 16, 2021

BUY
$28.45 - $38.0 $22.9 Million - $30.6 Million
805,816 New
805,816 $24.4 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.42B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.